Magentus has become the first company to sign Australia’s inaugural Voluntary Code of Conduct for the use of artificial intelligence in health software.
The Code was launched in December 2025 by the Medical Software Industry Association (MSIA) and the Medical Technology Association of Australia (MTAA), establishing the country’s first principles-based governance framework for AI in healthcare settings.
The Code covers 10 governance domains including accountability, risk management, data governance, transparency, testing and monitoring, and individuals’ rights to challenge AI-driven decisions.
Signatories commit to clear organisational ownership of AI, clinical validation prior to deployment, ongoing post-deployment monitoring, compliance with privacy law, and end-user transparency about how AI systems operate.
The framework aligns with the Australian Government’s National AI Plan, announced on 2 December 2025, and is accompanied by a companion Accreditation Standard. A formal review is scheduled for mid-2026.
Magentus Chief Technology Officer Brenden Conolly said the decision to sign was straightforward, and a clear sign of the commitment to ethical, responsible, and transparent use of AI.
“Patients, clinicians, and governments need to know that AI is being used carefully and transparently. This is about committing to exactly that, and earning their trust.”
Clear guardrails
Magentus is approaching AI use in its platforms with clear guardrails, including clarity on the point that it will not make clinical decisions. Under both the Code and the company’s own governance framework, clinicians remain in control at all times. AI support will be available to enhance administrative and workflow functions, acting as a care partner throughout the clinical journey.
Across Magentus’s broader portfolio, which supports pathology networks, oncology teams coordinating chemotherapy across multiple hospitals, and radiology departments managing growing diagnostic workloads, well-governed AI can help reduce duplicate testing, accelerate information flow, and free clinicians from time-consuming manual processes.
“AI isn’t about replacing expertise, it’s about removing the noise around it,” Mr Conolly said. “A well-designed system gives clinicians back time for direct patient care.”
Industry-led governance
The Code addresses a growing need for governance of health software that falls outside the Therapeutic Goods Administration’s regulatory remit, including practice management platforms, health informatics tools, and clinical workflow systems. Until now, no formal baseline existed for this category.
Magentus Managing Director of Practice Management & Oncology and MSIA Vice-President Michele Blanshard said the opportunities AI provides healthcare are exciting, but the industry needs to ensure every step is taken to ensure sound governance and transparency.
“We see responsible AI use as increasingly integral to providing safe, modern healthcare,” Ms Blanshard said. “We want to set the benchmark from the very beginning.”
